Skip to content
Radio Logo
PodcastsEducationOncology Today with Dr Neil Love

Oncology Today with Dr Neil Love

Dr. Neil Love
Latest episode

553 episodes

  • Oncology Today with Dr Neil Love

    GPRC5D-Directed Therapies for Multiple Myeloma — An Interview with Prof Rakesh Popat

    2026/11/20 | 55 mins.
    Featuring an interview with Prof Rakesh Popat, including the following topics:
    Overview of GPRC5D and its clinical significance (0:00)
    Key findings from Phase II TALisman study regarding dysgeusia assessment for patients receiving talquetamab (2:30)
    Mitigating dysgeusia and dry mouth arising from GPRC5D-directed therapy (6:25)
    Key findings from the Phase III MonumenTAL-3 study (11:49)
    Selection factors for GPRC5D- and BCMA-directed therapies (15:16)
    Managing extramedullary multiple myeloma (MM) with GPRC5D-targeted therapies and beyond (18:30)
    Key findings with arlocabtagene autoleucel (arlo-cel) for relapsed/refractory (R/R) MM (20:47)
    Ramantamig and other GPRC5D-targeted approaches (25:32)
    Comparing arlo-cel to ciltacabtagene autoleucel for MM; CNS issues with GPRC5D-directed therapies (28:42)
    Case: A man in his late 70s with a history of chronic obstructive pulmonary disease and t(4;14) R/R MM who receives fourth-line talquetamab and attains a very good partial response (38:27)
    Cases: A man in his late 40s with t(11;14), del(17p) R/R MM who enrolls in the Phase II QUINTESSENTIAL-2 study for third-line treatment; a man in his late 60s with t(11;14), del(17p) MM and early relapse after third-line autologous stem cell transplant (45:18)
    Guidance on sequencing BCMA- and GPRC5D-directed therapies (47:35)
    Importance of tumor debulking; access to arlo-cel (52:27)

    CME information and select publications
  • Oncology Today with Dr Neil Love

    Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab

    2026/11/16 | 15 mins.
    Featuring an interview with Dr Matthew Lunning, including the following topics:
    Tafasitamab for follicular lymphoma (0:00)
    frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

    CME information and select publications
  • Oncology Today with Dr Neil Love

    Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

    2026/11/13 | 57 mins.
    Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:
    Introduction (0:00)
    Prologue: Saturday Night Fever (1:35)
    Baby Boomers' Guide to Mechanisms of Action (3:07)
    Second-Line Treatment (12:36)
    Complications Associated with Bispecific Antibodies (23:41)
    Case Presentations (25:52)
    New Bispecific T-Cell Engagers — Surovatamig (26:24)
    Other Novel Agents (50:05)

    CME information and select publications
  • Oncology Today with Dr Neil Love

    Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    2026/11/11 | 1h 2 mins.
    Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:
    Multiple Myeloma (0:00)
    Introduction: ESMO 2026; Recent FDA Approvals (1:53)
    Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)
    Bispecific Antibodies — Dr Lonial (19:16)
    Antibody-Drug Conjugates — Dr Richardson (37:08)
    Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

    CME information and select publications
  • Oncology Today with Dr Neil Love

    Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    2026/11/10 | 58 mins.
    Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics:
    Introduction: ESMO 2026; Recent FDA Approvals (0:00)
    Selection of Endocrine Therapy — Dr Antonarakis (2:24)
    Utility of PARP Inhibitors — Dr Agarwal (22:59)
    AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42)
    Radiopharmaceuticals — Dr Agarwal (45:02)

    CME information and select publications
More Education podcasts
About Oncology Today with Dr Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Podcast website

Listen to Oncology Today with Dr Neil Love, Jim Rohn Motivation Daily and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Oncology Today with Dr Neil Love: Podcasts in Family